Journal of Ginseng Research

The Korean Society of Ginseng (고려인삼학회)
권호 표지
DOI QR코드

DOI QR Code

The anti-tumor efficacy of 20(S)-protopanaxadiol, an active metabolite of ginseng, according to fasting on hepatocellular carcinoma

  • Li, Wenzhen (Department of Pharmaceutical Sciences, Binzhou Medical University) ;
  • Wang, Yifan (Department of Pharmaceutical Sciences, Binzhou Medical University) ;
  • Zhou, Xinbo (Department of Pharmaceutical Sciences, Binzhou Medical University) ;
  • Pan, Xiaohong (Department of Pharmaceutical Sciences, Binzhou Medical University) ;
  • Lu, Junhong (Department of Pharmaceutical Sciences, Binzhou Medical University) ;
  • Sun, Hongliu (Department of Pharmaceutical Sciences, Binzhou Medical University) ;
  • Xie, Zeping (Department of Pharmaceutical Sciences, Binzhou Medical University) ;
  • Chen, Shayan (Department of Laboratory Science, Tianjin Medical University NanKai Hospital) ;
  • Gao, Xue (Department of Pharmaceutical Sciences, Binzhou Medical University)
  • Received : 2021.04.01
  • Accepted : 2021.06.01
  • Published : 2022.01.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: 20(S)-protopanaxadiol (20(S)-PPD), one of the main active metabolites of ginseng, performs a broad spectrum of anti-tumor effects. Our aims are to search out new strategies to enhance anti-tumor effects of natural products, including 20(S)-PPD. In recent years, fasting has been shown to be multi-functional on tumor progression. Here, the effects of fasting combined with 20(S)-PPD on hepatocellular carcinoma growth, apoptosis, migration, invasion and cell cycle were explored. Methods: CCK-8 assay, trypan blue dye exclusion test, imagings photographed by HoloMonitorTM M4, transwell assay and flow cytometry assay were performed for functional analyses on cell proliferation, morphology, migration, invasion, apoptosis, necrosis and cell cycle. The expressions of genes on protein levels were tested by western blot. Tumor-bearing mice were used to evaluate the effects of intermittent fasting combined with 20(S)-PPD. Results: We firstly confirmed that fasting-mimicking increased the anti-proliferation effect of 20(S)-PPD in human HepG2 cells in vitro. In fasting-mimicking culturing medium, the apoptosis and necrosis induced by 20(S)-PPD increased and more cells were arrested at G0-G1 phase. Meanwhile, invasion and migration of cells were decreased by down-regulating the expressions of matrix metalloproteinase (MMP)-2 and MMP-9 in fasting-mimicking medium. Furthermore, the in vivo study confirmed that intermittent fasting enhanced the tumor growth inhibition of 20(S)-PPD in H22 tumor-bearing mice without obvious side effects. Conclusion: Fasting significantly sensitized HCC cells to 20(S)-PPD in vivo and in vitro. These data indicated that dietary restriction can be one of the potential strategies of chinese medicine or its active metabolites against hepatocellular carcinoma.

Keywords

Acknowledgement

The study was supported by the grants from the Shandong Provincial Natural Science Foundation of China (ZR2018LH013), the Key Research and Development Plan of Yantai City (2019XDHZ098), the National Natural Science Foundation of China (81703846).

References

  1. Global Burden of Disease Liver Cancer C, Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, Allen C, Al-Raddadi R, Alvis-Guzman N, Amoako Y, et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015. JAMA Oncol 2017;3:1683-91. https://doi.org/10.1001/jamaoncol.2017.3055
  2. Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Niksic M, Bonaventure A, Valkov M, Johnson CJ, Esteve J, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 2018;391:1023-75. https://doi.org/10.1016/S0140-6736(17)33326-3
  3. De Mattia E, Cecchin E, Guardascione M, Foltran L, Di Raimo T, Angelini F, D'Andrea M, Toffoli G. Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma. World J Gastroenterol 2019;25:3870-96. https://doi.org/10.3748/wjg.v25.i29.3870
  4. Rimassa L, Pressiani T, Merle P. Systemic treatment options in hepatocellular carcinoma. Liver Cancer 2019;8:427-46. https://doi.org/10.1159/000499765
  5. Peng B, He R, Xu Q, Yang Y, Hu Q, Hou H, Liu X, Li J. Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway. Pharmacol Res 2019;142:1-13. https://doi.org/10.1016/j.phrs.2019.02.003
  6. Wang CZ, Zhang Z, Wan JY, Zhang CF, Anderson S, He X, Yu C, He TC, Qi LW, Yuan CS. Protopanaxadiol, an active ginseng metabolite, significantly enhances the effects of fluorouracil on colon cancer. Nutrients 2015;7:799-814. https://doi.org/10.3390/nu7020799
  7. Di Tano M, Raucci F, Vernieri C, Caffa I, Buono R, Fanti M, Brandhorst S, Curigliano G, Nencioni A, de Braud F, et al. Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers. Nat Commun 2020;11:2332. https://doi.org/10.1038/s41467-020-16243-3
  8. Caffa I, Spagnolo V, Vernieri C, Valdemarin F, Becherini P, Wei M, Brandhorst S, Zucal C, Driehuis E, Ferrando L, et al. Fasting-mimicking diet and hormone therapy induce breast cancer regression. Nature 2020;583:620-4. https://doi.org/10.1038/s41586-020-2502-7
  9. Safdie F, Brandhorst S, Wei M, Wang W, Lee C, Hwang S, Conti PS, Chen TC, Longo VD. Fasting enhances the response of glioma to chemo- and radiotherapy. PLoS One 2012;7:e44603. https://doi.org/10.1371/journal.pone.0044603
  10. McClure CD, Zhong W, Hunt VL, Chapman FM, Hill FV, Priest NK. Hormesis results in trade-offs with immunity. Evolution 2014;68:2225-33. https://doi.org/10.1111/evo.12453
  11. Liu B, Li X, Sun F, Tong X, Bai Y, Jin K, Liu L, Dai F, Li N. HP-CagA+ regulates the expression of CDK4/CyclinD1 via reg3 to change cell cycle and promote cell proliferation. Int J Mol Sci 2019;21.
  12. Khemlina G, Ikeda S, Kurzrock R. The biology of Hepatocellular carcinoma: implications for genomic and immune therapies. Mol Cancer 2017;16:149. https://doi.org/10.1186/s12943-017-0712-x
  13. Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, Luo R, Feng J, Ye S, Yang TS, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 2009;10:25-34. https://doi.org/10.1016/S1470-2045(08)70285-7
  14. Kudo M. Recent advances in systemic therapy for hepatocellular carcinoma in an aging society: 2020 update. Liver Cancer 2020;9:640-62. https://doi.org/10.1159/000511001
  15. Lin K, Liu B, Lim SL, Fu X, Sze SC, Yung KK, Zhang S. 20(S)-protopanaxadiol promotes the migration, proliferation, and differentiation of neural stem cells by targeting GSK-3beta in the Wnt/GSK-3beta/beta-catenin pathway. J Ginseng Res 2020;44:475-82. https://doi.org/10.1016/j.jgr.2019.03.001
  16. Jiang N, Jingwei L, Wang H, Huang H, Wang Q, Zeng G, Li S, Liu X. Ginsenoside 20(S)-protopanaxadiol attenuates depressive-like behaviour and neuro-inflammation in chronic unpredictable mild stress-induced depressive rats. Behav Brain Res 2020;393:112710. https://doi.org/10.1016/j.bbr.2020.112710
  17. Jo H, Jang D, Park SK, Lee MG, Cha B, Park C, Shin YS, Park H, Baek JM, Heo H, et al. Ginsenoside 20(S)-protopanaxadiol induces cell death in human endometrial cancer cells via apoptosis. J Ginseng Res 2021;45:126-33. https://doi.org/10.1016/j.jgr.2020.02.002
  18. Lu Z, Xu H, Yu X, Wang Y, Huang L, Jin X, Sui D. 20(S)-Protopanaxadiol induces apoptosis in human hepatoblastoma HepG2 cells by downregulating the protein kinase B signaling pathway. Exp Ther Med 2018;15:1277-84.
  19. Jordan S, Tung N, Casanova-Acebes M, Chang C, Cantoni C, Zhang D, Wirtz TH, Naik S, Rose SA, Brocker CN, et al. Dietary intake regulates the circulating inflammatory monocyte pool. Cell 2019;178:1102-1114 e1117. https://doi.org/10.1016/j.cell.2019.07.050
  20. Brandhorst S, Choi IY, Wei M, Cheng CW, Sedrakyan S, Navarrete G, Dubeau L, Yap LP, Park R, Vinciguerra M, et al. A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan. Cell Metab 2015;22:86-99. https://doi.org/10.1016/j.cmet.2015.05.012
  21. Di Biase S, Lee C, Brandhorst S, Manes B, Buono R, Cheng CW, Cacciottolo M, Martin-Montalvo A, de Cabo R, Wei M, et al. Fasting-mimicking diet reduces HO-1 to promote T cell-mediated tumor cytotoxicity. Cancer Cell 2016;30:136-46. https://doi.org/10.1016/j.ccell.2016.06.005
  22. Li Z, Takino T, Endo Y, Sato H. Activation of MMP-9 by membrane type-1 MMP/MMP-2 axis stimulates tumor metastasis. Cancer Sci 2017;108:347-53. https://doi.org/10.1111/cas.13134
  23. Liu Q, Liu X, Gao J, Shi X, Hu X, Wang S, Luo Y. Overexpression of DOC-1R inhibits cell cycle G1/S transition by repressing CDK2 expression and activation. Int J Biol Sci 2013;9:541-9. https://doi.org/10.7150/ijbs.5763
  24. Bacevic K, Lossaint G, Achour TN, Georget V, Fisher D, Dulic V. Cdk2 strengthens the intra-S checkpoint and counteracts cell cycle exit induced by DNA damage. Sci Rep 2017;7:13429. https://doi.org/10.1038/s41598-017-12868-5